APA
BOLD

American Portfolios Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History

American Portfolios Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50
Closed -$1.41K – 2955
2019
Q3 		$1.41K Hold
50
– – ﹤0.01% 2591
2019
Q2 		$1.89K Hold
50
– – ﹤0.01% 2495
2019
Q1 		$1.95K Hold
50
– – ﹤0.01% 2386
2018
Q4 		$1.07K Hold
50
– – ﹤0.01% 2249
2018
Q3 		$1.98K Hold
50
– – ﹤0.01% 2231
2018
Q2 		$1.91K Buy
+50
New +$1.85K ﹤0.01% 2198

Other funds holding BOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

American Portfolios Advisors's BOLD Position: Q4 2019 in Review

American Portfolios Advisors sold out of Audentes Therapeutics, Inc (BOLD) in Q4 2019, closing a stake of 50 shares — an estimated $1.41K sold.

American Portfolios Advisors first reported a position in BOLD in Q2 2018 and held it in 6 quarters. The position peaked at $1.98K in Q3 2018. 188 funds tracked by Wall St. Rank hold BOLD as of Q4 2019.

  • American Portfolios Advisors reported no remaining Audentes Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
  • American Portfolios Advisors sold 50 Audentes Therapeutics, Inc shares in Q4 2019, an estimated $1.41K.
  • American Portfolios Advisors first reported a position in Audentes Therapeutics, Inc in Q2 2018 and held it in 6 quarters.
  • American Portfolios Advisors's Audentes Therapeutics, Inc position peaked at $1.98K in Q3 2018.
  • 188 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2019.

Based on American Portfolios Advisors's 13F filing for Q4 2019, filed 24 Mar 2023.